Updated hourlyHourly refreshTue, Sep 22, 2026
Press Release Database
Recent press releases, indexed by topic.
SaaS · Healthcare
AUSTIN, Texas, September 14, 2026--Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore and enhance human capabilities, today announced that the first participant implanted with the Connexus® BCI has successfully used the system for real-time speech and text communication. The milestone was achieved as part of the Connect-One Early Feasibility Study, conducted under an FDA-approved Investigational Device Exemption (ID
Sep 14 · 18:57·mlpr-businesswire
Healthcare
LOS ANGELES, September 14, 2026--Ammortal, the human optimization company focused on elevating potential through advanced technology and transcendent experience, today announced the expansion of its partnership with Next Health, the most advanced and comprehensive brand of health optimization and longevity centers, following the partnership’s introduction at Next Health’s annual summit. The Ammortal Chamber is now available at three Next Health locations, with plans to expand to additional locat
Sep 14 · 18:31·mlpr-businesswire
Healthcare
The national telepsychiatry practice appoints Kara Birch, DNP, PMHNP-BC, FNP-BC, and Anna Lau, MSN, PMHNP-BC, WHNP-BC, to strengthen clinical excellence and nursing operations. NEW YORK, Sept. 14, 2026 /PRNewswire/ -- As telepsychiatry expands access to mental health care, maintaining...
Sep 14 · 18:29·PR Newswire
Healthcare
WOIPPY, France, September 14, 2026--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services, informs its shareholders and the broader financial community that the latest equity research report on the Company, prepared by All Invest Securities, is now available.
Sep 14 · 18:00·mlpr-businesswire
Finance · Healthcare
This acquisition expands Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic. RALEIGH, N.C. and BOSTON, Sept. 14, 2026 /PRNewswire/ -- Endpoint Clinical L.P., a global leader in randomization and trial supply management ("RTSM") solutions and a...
Sep 14 · 18:00·mlpr-prnewswire-wire
Healthcare
Dr. Gregory Gasbarro Leads Introduction of Advanced Robotic-Arm Assisted Shoulder Arthroplasty at Mercy BALTIMORE, Sept. 14, 2026 /PRNewswire/ -- Mercy Medical Center is advancing orthopedic care in the Mid-Atlantic region with the introduction of Mako SmartRobotics™ technology for...
Sep 14 · 18:00·mlpr-prnewswire-wire
Healthcare
Today marks the beginning of Fungal Disease Awareness Week (FDAW), observed September 14–18. Established by the Centers for Disease Control and Prevention (CDC), the annual observance raises awareness about fungal diseases, their impact on public health, and the importance of prevention, early recognition, accurate diagnosis, and appropriate treatment. - - Fungal diseases can affect people in many settings, and the risk may be particularly important in Puerto Rico and throughout the Caribbe... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360478
Sep 14 · 17:36·WebWire
Healthcare
WASHINGTON, Sept. 14, 2026 /PRNewswire/ -- The National Hispanic Health Foundation (NHHF), National Minority Quality Forum (NMQF), Association of American Medical Colleges (AAMC), and National Hispanic Medical Association (NHMA) will come together on Wednesday, September 16, for the 2026...
Sep 14 · 17:34·PR Newswire
Finance · SaaS
San Diego, California--(Newsfile Corp. - September 14, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, inclusive (the "Class Period"). Hims operates a health and wellness platform that connects consumers to licensed healthcare professionals.The complaint alleges that Hims & Hers shared...
Sep 14 · 17:30·mlpr-newsfile
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 14, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE:HIMS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: ..
Sep 14 · 17:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 14, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SELLAS Life Sciences Group, Inc. ("SELLAS" or "the Company") (NASDAQ:SLS). Investors who purchased SELLAS securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/sellas-life-sciences-group-inc-sls-class_action_lawsuit. SELLAS Investigation Details On August 28, 2026, a news site reported that the Company's phase 3 clinical trial for Galinpepimut-S (GPS) had reached its 80th patient death, a pre-specified event that was to trigger the release of results for the clinical trial. However, as of ..
Sep 14 · 17:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 14, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ:GUTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/cases/fractyl-health-inc-guts-class_action_lawsuit. Fractyl Case ..
Sep 14 · 17:02·PR-Inside